Why is Clinitech Lab falling/rising?

As of 04-Sep, Clinitech Laboratory Ltd's stock price is currently at Rs 51.00, reflecting an increase of Rs 2.19 or 4.49%. The stock has shown a positive performance today, outperforming its sector by 3.62% and opening with a gain of 4.71%. It reached an intraday high of Rs 51.15, indicating strong upward momentum. However, the stock has experienced erratic trading, not trading on 2 out of the last 20 days, and there has been a significant decline in investor participation, with delivery volume dropping by 78.26% against the 5-day average. Year-to-date, the stock has declined by 35.33%, contrasting sharply with the Sensex, which has gained 3.30% over the same period.
In the broader market context, Clinitech's short-term return of 2.00% over the past week outperformed the Sensex, which only increased by 0.80%. Despite this recent uptick, the stock's year-to-date and one-year performance remains significantly negative, with declines of 35.33% and 38.55%, respectively, while the Sensex has shown resilience. The stock's moving averages indicate mixed signals, being higher than the 20-day and 50-day averages but lower than the 5-day, 100-day, and 200-day averages, suggesting volatility in its trading pattern. Overall, while there are some positive indicators in the short term, the long-term performance and declining investor interest present challenges for Clinitech Laboratory Ltd.